lorazepam has been researched along with prochlorperazine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bishop, JF; Buchanan, L; Matthews, JP; Oliver, IN; Reynolds, S; Rischin, D; Tan, LG; Walpole, E; Wolf, MM | 1 |
| Beaulieu, R; Courchesne, Y; Latreille, J; Letendre, F; Lorange, A; Louvet, C; Monte, M; Neemeh, JA; Pretty, HM | 1 |
| Ackland, S; Bishop, JF; Cooper, IA; Hillcoat, BL; Matthews, JP; Morton, C; Scott, K; Wolf, M; Yuen, K | 1 |
| Bingham, J; Bishop, JF; Cooper, IA; Hillcoat, BL; Long, M; Matthews, JP; Olver, IN; Wolf, MM | 1 |
| Bishop, JF; Matthews, JP; Olver, IN; Smith, RA | 1 |
| Fanning, J; Hilgers, RD | 1 |
| Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G | 1 |
| Bearman, SI; Cagnoni, PJ; Day, TC; Jones, RB; Matthes, S; Shpall, EJ | 1 |
| Baggstrom, MQ; Chitneni, P; Gao, F; Govindan, R; Mann, J; Morgensztern, D; Waqar, MA; Waqar, SN; Williams, K | 1 |
1 review(s) available for lorazepam and prochlorperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for lorazepam and prochlorperazine
| Article | Year |
|---|---|
A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.
Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Vomiting | 1992 |
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Prochlorperazine; Random Allocation; Vomiting | 1987 |
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting | 1984 |
The roles of patient and observer assessments in anti-emetic trials.
Topics: Cross-Over Studies; Double-Blind Method; Humans; Lorazepam; Metoclopramide; Nurses; Observer Variation; Patients; Prochlorperazine; Time Factors; Treatment Outcome; Vomiting | 1994 |
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lorazepam; Metoclopramide; Ondansetron; Ovarian Neoplasms; Prochlorperazine; Severity of Illness Index; Single-Blind Method; Treatment Failure; Vomiting | 1994 |
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Clinical Protocols; Cyclophosphamide; Diphenhydramine; Double-Blind Method; Dronabinol; Female; Humans; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Placebos; Prochlorperazine; Transplantation, Autologous; Vomiting | 1995 |
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carmustine; Cisplatin; Cross-Linking Reagents; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lorazepam; Lung; Male; Middle Aged; Ondansetron; Prochlorperazine; Radiation-Sensitizing Agents; Retrospective Studies; Transplantation, Autologous | 1999 |
4 other study(ies) available for lorazepam and prochlorperazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
Topics: Acute Disease; Antiemetics; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Humans; Lorazepam; Metoclopramide; Nausea; Prochlorperazine; Time Factors; Vomiting | 1991 |
Delayed nausea and vomiting from carboplatin doublet chemotherapy.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Prospective Studies; Surveys and Questionnaires; Vomiting | 2016 |